Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    XOMA Royalty Corporation 8.625% Perpetual Preferred Stock Series A (XOMAP) Insider Trading Activity

    Healthcare • Biotechnology • 13 employees

    XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

    Total Value

    -$17,931,713.15

    Total Shares

    -611,240

    Average Trade Value

    -$2,241,464.14

    Most Active Insider

    Bvf Partners L P/Il

    Total Activity: $16,983,714

    Largest Single Transaction

    $8,865,622

    by Bvf Partners L P/Il on Jan 24, 2025

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    10% Owner
    Jan 24, 2025 75,287 $1,964,991 0 Sale
    10% Owner
    Jan 24, 2025 339,679 $8,865,622 1,450,165 (-23.4%) Sale
    10% Owner
    Jan 24, 2025 85,776 $2,238,754 1,532,861 (-5.6%) Sale
    10% Owner
    Jan 24, 2025 149,975 $3,914,348 0 Sale
    Svp, Finance CFO
    Nov 13, 2024 9,775 $292,664 14,553 (-67.2%) Sale
    Chief Executive Officer
    Nov 13, 2024 21,881 $655,336 34,979 (-62.6%) Sale
    Svp, Finance CFO
    Nov 11, 2024 17,773 $0 24,328 (+73.1%) Exercise/Conversion
    Chief Executive Officer
    Nov 11, 2024 53,360 $0 56,860 (+93.8%) Exercise/Conversion